The bill establishes a new section in Florida law, 499.0296, which focuses on the treatment of chronic and terminal illnesses. It defines key terms such as "chronically ill patient" and "terminally ill patient," outlining their rights to determine their treatment courses with the assistance of healthcare providers. The bill authorizes compounding pharmacies to obtain specific active pharmaceutical ingredients for individualized treatments, provided these ingredients meet certain quality and safety conditions.

Additionally, the bill stipulates that compounding pharmacies can source active pharmaceutical ingredients that lack a monograph from recognized pharmacopoeias, as long as they are purchased from registered manufacturers and comply with state laws. It explicitly prohibits any treatment intended to cause a patient's death. The act is set to take effect on July 1, 2025.